AbbVie 거래 ABBV

매도
 매수

AbbVie 실시간 차트

5m 15m 30m 1h 4h 1d 1w

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

최신 뉴스

Frances Wang 2025 Apr 13, 16:00

Bitcoin price today: what’s going on with Solana, XRP, and Dogecoin?

Cryptocurrencies
Frances Wang 2025 Apr 13, 16:00

Stock Market Today: Dow, S&P 500, and Nasdaq Futures Start Off Stronger

Indices Stocks
Tommy Yap 2025 Apr 13, 16:00

Morning Note: Tariff Chaos Shakes Dollar Confidence; BoE Cautious; Yen Gains

Morning Note Forex
Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices
Frances Wang 2025 Apr 10, 16:00

ETF Market Today: SUI ETF Filing Signals Altcoin Market Expansion

Cryptocurrencies ETFs
Frances Wang 2025 Apr 10, 16:00

BTC news today: Bitcoin Price Surges to $81K on Trump's Tariff Pause

Cryptocurrencies
Frances Wang 2025 Apr 09, 16:00

Stock indices today: Nikkei 225 Rebounds After Yen Weakens Against Dollar

Indices
Tommy Yap 2025 Apr 09, 16:00

Morning Note: Trump Tariff U-Turn, US Inflation Awaited, Japan PPI Up

Morning Note

정보

스프레드

1.19

스프레드(%)

0.6681 %

레버리지

1:10

익일 이자 매수

-0.0597 %

익일 이자 매도

-0.0292 %

통화

USD

거래 시간

시장 개장

월요일

13:31 - 19:59

화요일

13:31-19:59

수요일

13:31-19:59

목요일

13:31-19:59

금요일

13:31-19:59

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

309659959296

발행 주식 수

1768979968

수익 날짜 (다음)

0000-00-00

배당수익률

2025-05-15

배당락일

2025-04-15

예상 연간 배당금

6.56

예상 연간 배당수익률

0.0375

EPS

2.4

이 상품에 대해 자세히 알아보기

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

관련 상품

자산
매도
매수
변동(%)

지금 거래하기

지금 거래하기

지금 거래하기

지금 거래하기
view_all_instruments
Trustpilot